A generic integrated physiologically based whole-body model of the glucose insulin-glucagon regulatory system

CPT: Pharmacometrics and Systems Pharmacology

Volumn 2, Issue 8, 2013, Pages

  Schaller, S ^a,b   Willmann, S ^a   Lippert, J ^a   Schaupp, L ^c   Pieber, T R ^c   Schuppert, A ^a,b   Eissing, T ^a  

^a BAYER AG   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; INCRETIN; INSULIN; INSULIN RECEPTOR; SODIUM GLUCOSE COTRANSPORTER 1; SODIUM GLUCOSE COTRANSPORTER 2;

ABSORPTION; ARTICLE; BIOLOGICAL MODEL; BLOOD FLOW; BLOOD GLUCOSE MONITORING; CLEARANCE; COMPARTMENT MODEL; COMPUTER MODEL; DIABETIC PATIENT; GLUCOSE ABSORPTION; GLUCOSE METABOLISM; HUMAN; HYPOGLYCEMIA; INDIVIDUALIZATION; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN TOLERANCE TEST; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN CONTENT; REGULATORY MECHANISM;

EID: 84883442462     PISSN: None     EISSN: 21638306     Source Type: Journal    
DOI: 10.1038/psp.2013.40     Document Type: Article

References (50)

1. International-Diabetes-Federation. IDF Diabetes Atlas. (International Diabetes Federation, Brussels, Belgium, 2011).
2. Ban, K., Hui, S., Drucker, D.J. & Husain, M. Cardiovascular consequences of drugs used for the treatment of diabetes: potential promise of incretin-based therapies. J. Am. Soc. Hypertens. 3, 245-259 (2009).
3. Charbonnel, B. & Cariou, B. Pharmacological management of type 2 diabetes: the potential of incretin-based therapies. Diabetes. Obes. Metab. 13, 99-117 (2011).
4. El Youssef, J., Castle, J. & Ward, W.K. A review of closed-loop algorithms for glycemic control in the treatment of type 1 diabetes. Algorithms 2(1), 518-532 (2009).
5. Hovorka, R. Closed-loop insulin delivery: from bench to clinical practice. Nat. Rev. Endocrinol. 7, 385-395 (2011).
6. BOLIE, V.W. Coefficients of normal blood glucose regulation. J. Appl. Physiol. 16, 783-788 (1961).
7. Bergman, R.N., Ider, Y.Z., Bowden, C.R. & Cobelli, C. Quantitative estimation of insulin sensitivity. Am. J. Physiol. 236, E667-E677 (1979).
8. Renard, E. Closed-loop insulin delivery: is the Holy Grail near? Lancet 375, 702-703 (2010).
9. Dalla Man, C., Rizza, R.A. & Cobelli, C. Meal simulation model of the glucose-insulin system. IEEE Trans. Biomed. Eng. 54, 1740-1749 (2007).
10. Kovatchev, B.P., Breton, M., Man, C.D. & Cobelli, C. In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. J. Diabetes Sci. Technol. 3, 44-55 (2009).
11. Hovorka, R., Chassin, L.J., Ellmerer, M., Plank, J. & Wilinska, M.E. A simulation model of glucose regulation in the critically ill. Physiol. Meas. 29, 959-978 (2008).
12. Dassau, E., Atlas, E. & Phillip, M. Closing the loop. Int. J. Clin. Pract. Suppl. 65, 20-25 (2010).
13. Sorensen, J.T. A Physiologic Model of Glucose Metabolism in Man and its Use to Design and Assess Improved Insulin Therapies for Diabetes. PhD thesis, MIT (1985).
14. Parker, R.S., Doyle, F.J. 3rd & Peppas, N.A. A model-based algorithm for blood glucose control in type I diabetic patients. IEEE Trans. Biomed. Eng. 46, 148-157 (1999).
15. Eissing, T. et al. A computational systems biology software platform for multiscale modeling and simulation: integrating whole-body physiology, disease biology, and molecular reaction networks. Front. Physiol. 2, 4 (2011).
16. Strougo, A., Eissing, T., Yassen, A., Willmann, S., Danhof, M. & Freijer, J. First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug development. J. Pharmacokinet. Pharmacodyn. 39, 195-203 (2012).
17. Thelen, K., Coboeken, K., Willmann, S., Burghaus, R., Dressman, J.B. & Lippert, J. Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part 1: oral solutions. J. Pharm. Sci. 100, 5324-5345 (2011).
18. Mosekilde, E., Jensen, K.S., Binder, C., Pramming, S. & Thorsteinsson, B. Modeling absorption kinetics of subcutaneous injected soluble insulin. J. Pharmacokinet. Biopharm. 17, 67-87 (1989).
19. Tarín, C., Teufel, E., Picó, J., Bondia, J. & Pfleiderer, H.J. Comprehensive pharmacokinetic model of insulin Glargine and other insulin formulations. IEEE Trans. Biomed. Eng. 52, 1994-2005 (2005).
20. Bodenlenz, M. et al. Measurement of interstitial insulin in human adipose and muscle tissue under moderate hyperinsulinemia by means of direct interstitial access. Am. J. Physiol. Endocrinol. Metab. 289, E296-E300 (2005).
21. Barrett, E.J., Wang, H., Upchurch, C.T. & Liu, Z. Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature. Am. J. Physiol. Endocrinol. Metab. 301, E252-E263 (2011).
22. Dalla Man, C., Rizza, R.A. & Cobelli, C. Mixed meal simulation model of glucose-insulin system. Conf. Proc. IEEE Eng. Med. Biol. Soc. 1, 307-310 (2006).
23. Markakis, M.G., Mitsis, G.D. & Marmarelis, V.Z. Computational study of an augmented minimal model for glycaemia control. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2008, 5445-5448 (2008).
24. Willmann, S. et al. PK-Sim® : a physiologically based pharmacokinetic 'whole-body' model. Biosilico 1, 121-124 (2003).
25. Quon, M.J. & Campfield, L.A. A mathematical model and computer simulation study of insulin receptor regulation. J. Theor. Biol. 150, 59-72 (1991).
26. Koschorreck, M. & Gilles, E.D. Mathematical modeling and analysis of insulin clearance in vivio. BMC Syst. Biol. 2, 43 (2008).
27. Huber, C.T., Solomon, S.S. & Duckworth, W.C. Time-course of insulin degradation in perifused isolated rat adipose cells. J. Clin. Invest. 65, 461-468 (1980).
28. Duckworth, W.C., Bennett, R.G. & Hamel, F.G. Insulin degradation: progress and potential. Endocr. Rev. 19, 608-624 (1998).
29. El-Khatib, F.H., Russell, S.J., Nathan, D.M., Sutherlin, R.G. & Damiano, E.R. A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci. Transl. Med. 2, 27ra27 (2010).
30. Zierler, K. Whole body glucose metabolism. Am. J. Physiol. 276, E409-E426 (1999).
31. Regittnig, W. et al. Plasma and interstitial glucose dynamics after intravenous glucose injection: evaluation of the single-compartment glucose distribution assumption in the minimal models. Diabetes 48, 1070-1081 (1999).
32. Chen, C.L., Tsai, H.W. & Wong, S.S. Modeling the physiological glucose-insulin dynamic system on diabetics. J. Theor. Biol. 265, 314-322 (2010).
33. Magni, L. et al. Model predictive control of type 1 diabetes: an in silico trial. J. Diabetes Sci. Technol. 1, 804-812 (2007).
34. Di Guglielmo, G.M., Drake, P.G., Baass, P.C., Authier, F., Posner, B.I. & Bergeron, J.J. Insulin receptor internalization and signalling. Mol. Cell. Biochem. 182, 59-63 (1998).
35. Bottaro, D.P., Bonner-Weir, S. & King, G.L. Insulin receptor recycling in vascular endothelial cells. Regulation by insulin and phorbol ester. J. Biol. Chem. 264, 5916-5923 (1989).
36. Gorden, P., Arakaki, R., Collier, E. & Carpentier, J.L. Biosynthesis and regulation of the insulin receptor. Yale J. Biol. Med. 62, 521-531 (1989).
37. Hovorka, R. et al. Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiol. Meas. 25, 905-920 (2004).
38. Puig, O. & Tjian, R. Transcriptional feedback control of insulin receptor by dFOXO/FOXO1. Genes Dev. 19, 2435-2446 (2005).
39. Tolic, I.M., Mosekilde, E. & Sturis, J. Modeling the insulin-glucose feedback system: the significance of pulsatile insulin secretion. J. Theor. Biol. 207, 361-375 (2000).
40. Richter, E.A., Nielsen, J.N., Jørgensen, S.B., Frøsig, C., Birk, J.B. & Wojtaszewski, J.F. Exercise signalling to glucose transport in skeletal muscle. Proc. Nutr. Soc. 63, 211-216 (2004).
41. Chalhoub, E., Xie, L., Balasubramanian, V., Kim, J. & Belovich, J. A distributed model of carbohydrate transport and metabolism in the liver during rest and high-intensity exercise. Ann. Biomed. Eng. 35, 474-491 (2007).
42. Galgani, J., Aguirre, C. & Díaz, E. Acute effect of meal glycemic index and glycemic load on blood glucose and insulin responses in humans. Nutr. J. 5, 22 (2006).
43. Fleisher, D., Li, C., Zhou, Y., Pao, L.H. & Karim, A. Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications. Clin. Pharmacokinet. 36, 233-254 (1999).
44. Jockel, J.P., Roebrock, P. & Shergold, O.A. Insulin depot formation in subcutaneoue tissue. J. Diabetes Sci. Technol. 7, 227-237 (2013).
45. Schade, D.S. & Duckworth, W.C. In search of the subcutaneous-insulin- resistance syndrome. N. Engl. J. Med. 315, 147-153 (1986).
46. Saad, A. et al. Diurnal pattern to insulin secretion and insulin action in healthy individuals. Diabetes 61(11), 2691-2700 (2012).
47. Hagström-Toft, E., Bolinder, J., Ungerstedt, U. & Arner, P. A circadian rhythm in lipid mobilization which is altered in IDDM. Diabetologia 40, 1070-1078 (1997).
48. Bollen, M., Keppens, S. & Stalmans, W. Specific features of glycogen metabolism in the liver. Biochem. J. 336 (Pt 1), 19-31 (1998).
49. Hetherington, J. et al. A composite computational model of liver glucose homeostasis. I. Building the composite model. J. R. Soc. Interface 9, 689-700 (2012).
50. Services BT. SB Model Suite 5.1.4-users manual. (2012).